Dasatinib Modulates Invasive and Migratory Properties of Canine Osteosarcoma and has Therapeutic Potential in Affected Dogs

por Marley, Kevin, Gullaba, Justine, Seguin, Bernard, Gelberg, Howard B., Helfand, Stuart C.
Publicado 2015

Antiproliferative effects of masitinib and imatinib against canine oral fibrosarcoma in vitro

por Milovancev, Milan, Helfand, Stuart C., Marley, Kevin, Goodall, Cheri P., Löhr, Christiane V., Bracha, Shay
Publicado 2016

The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma in vitro

por Marley, Kevin, Helfand, Stuart C, Edris, Wade A, Mata, John E, Gitelman, Alix I, Medlock, Jan, Séguin, Bernard
Publicado 2013

Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma

por Marley, Kevin, Helfand, Stuart C, Simpson, Jennifer, Mata, John E, Tracewell, William G, Brownlee, Lisa, Bracha, Shay, Séguin, Bernard
Publicado 2013

Vaccine-induced ErbB (EGFR/HER2)-specific immunity in spontaneous canine cancer

por Doyle, Hester A., Gee, Renelle J., Masters, Tyler D., Gee, Christian R., Booth, Carmen J., Peterson-Roth, Elizabeth, Koski, Raymond A., Helfand, Stuart C., Price, Lauren, Bascombe, Deborah, Jackson, Dorothy, Ho, Rita, Post, Gerald R., Mamula, Mark J.
Publicado 2021